• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, August 13, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

How COVID-19 changed the way patients responded to a heart attack

Bioengineer by Bioengineer
August 3, 2020
in Health
Reading Time: 7 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: University of Leeds

The death rate for patients who experienced what is normally a lower-risk heart attack rose sharply during the peak of the COVID-19 pandemic in England, according to an analysis of NHS data.

In comparison, the death rate for people who had a more severe heart attack fell.

It also revealed a substantial drop in the number of people who were arriving at hospital with a heart attack. At its lowest point, hospitals were treating just over half the cases they would normally expect to see.

Although the number of people seeking medical help did rebound, they had not returned to their pre COVID-19 levels by 22 May, when the study period ended.

The reduction in patients seeking timely help is likely to have resulted in people dying at home or developing chronic heart problems.

Despite the pressures on the NHS from COVID-19, the study showed that hospitals were able to maintain their emergency cardiac services in the vast majority of cases and adhere to best-practice clinical guidelines.

The study is the first detailed insight into what happened to heart attack patients as the NHS reorganised services to focus on COVID-19. The investigation was only possible after Ministers sanctioned access to anonymised patient data.

It was led by the University of Leeds in collaboration with Leeds Teaching Hospitals NHS Trust, the University of Keele, Imperial College, Barts Health NHS Trust, University College, London and Glangwili General Hospital, Carmarthen, Wales.

Researchers analysed admission data for 50,689 patients who had a heart attack and were treated at 99 acute NHS hospitals in England over the 14 months prior to UK lockdown on 23 March, and the first two months of lockdown.

The study was endorsed by Sir Patrick Vallance, the Government’s Chief Scientific Advisor. He wanted scientists to investigate how patients and healthcare providers responded during the peak of the pandemic to help inform future NHS planning.

The findings are published in the European Heart Journal – Quality of Care and Clinical Outcomes.

Dr Jianhua Wu, Associate Professor in Biostatistics at the University of Leeds and lead author of the study, said: “The data have given us a very detailed picture of the way patient behaviour changed as COVID-19 swept across Europe.

“It has revealed that although patients were able to get access to high levels of care, the study suggests a lot of very ill people were not seeking emergency treatment and that may have been an unintended consequence of the ‘Stay at Home’ messaging.”

Chris Gale, Professor of Cardiovascular Medicine at the University of Leeds and senior author of the study, said: “This national picture provides evidence for the devastating impact that the COVID-19 pandemic has had on people’s lives. The inflation in deaths among people attending hospital with heart attack is very likely an early signal of the mortality and morbidity that is yet to be observed.

“Notably, we have not seen a return to the normal rates of admissions with heart attack. This means that people may still be delaying seeking help.”

Don’t delay seeking help

Dr Sonya Babu-Narayan, Associate Medical Director at the British Heart Foundation, said: “We know that throughout lockdown fewer people were treated for a heart attack, risking death or long-term heart damage.

“If you experience chest pain or discomfort, which may feel like squeezing or heaviness or tightness not necessarily the chest-clutching agony that we see on TV and which may radiate to your jaw, arm, back or stomach, it’s important to understand you could be having a heart attack.

“Thanks to decades of research, prompt treatment for your heart attack could save your life, so if you think you are experiencing symptoms call 999 immediately.”

What the study found

The analysis looked at two types of heart attack – 17,246 people who had a STEMI heart attack and 33,443 who had a NSTEMI heart attack (total patients: 50,698).

An NSTEMI is the most common form of heart attack and usually happens when there is a partial blockage to one of the blood vessels supplying the heart.

A STEMI heart attack is where there is a complete blockage of one of the blood vessels that takes oxygen to the heart.

The statistical analysis revealed that significantly fewer people were attending hospital with a heart attack. NSTEMI cases were down by 49 percent – and STEMI by 29 percent on what hospitals were expecting to see.

The graph with this story shows the 7-day moving average for the number of people admitted to hospital for two types of heart attack: NSTEMI and STEMI. Key dates in the spread of the pandemic around the world are also highlighted.

If you re-produce the graph, please credit: University of Leeds

The decline in patients attending hospital started in early 2020 as China implemented lockdown measures and the World Health Organisation announced a public health emergency. And that decline continued through the early part of the lockdown in the UK.

The smallest number of cases was seen on 19 April where the 99 hospitals recorded 60 heart attack cases. They would normally expect to see around 104.

Professor Gale said: “It was not the case that people were not having heart attacks – they were deciding not to go to hospital. Some were undoubtedly heeding the message to stay at home, others might have been afraid of picking up the virus in hospital or were trying to shield because they had other conditions.

“The study has revealed that patient behaviour was beginning to shift as reports emerged of the pressure COVID-19 was having on other healthcare systems.

“But a heart attack is a medical emergency and if people do not seek help, they die or go on to develop heart failure. We need to make sure people are aware that emergency services continued to operate.”

The analysis showed that by 22 May, the number of heart attack cases that hospitals were seeing had not returned to pre-lockdown levels.

For patients experiencing a STEMI heart attack, the preferred treatment is primary percutaneous coronary intervention, where a balloon inside a catheter is inserted into the artery to clear the blockage. The NHS was able to maintain the treatment in the vast majority of cases. A small number, 0.3 percent, were treated with clot-busting drugs instead.

Most of the patients having an NSTEMI heart attack were able to have coronary angiography, a technique that uses dyes and x-rays to pinpoint exactly where blood vessels are obstructed. But in an additional three percent of cases that did not happen.

People dying within a month of a heart attack

In the month after lockdown started, the proportion of patients who had an NSTEMI heart attack and died within a month went from 5.4 percent to 7.5 percent, an increase of 39 percent. It dropped back to 5 percent over the following four weeks.

During the same period, patients who had a STEMI heart attack, the 30-day mortality figure dropped from 10.2 percent to 7.7 percent, a 25 percent reduction. Over the subsequent four weeks, it increased slightly to 8.3 percent.

As a statistical analysis, the study cannot identify the precise reasons for the fluctuation in the death rates but it is believed to be linked to the fall in patients seeking help, particularly among NSTEMI patients who may not display the classic symptoms of a heart attack such as chest pain.

Professor Gale said: “We can only speculate as to why there has been an increase in deaths among patients with NSTEMI, despite good care in hospital. It is possible that these patients had the COVID19 infection which contributed to their death.”

What the findings mean for healthcare planning

Professor Gale said the study showed that emergency cardiac services were able to maintain their effectiveness during the peak of the pandemic. But he warned: “There is little doubt that the substantial drop in admissions to hospital with heart attack will have had substantial repercussions on population health outcomes.

“People will have died or developed heart failure as a result of not seeking treatment for their heart attack. The NHS now needs to be ready to support those who did not attend hospital.”

###

Note to Editors

To interview any of the researchers, please contact David Lewis in the University of Leeds press office: [email protected] or 07710 013287

Caption for the graphic: The graph shows the 7-day moving average for the number of people admitted to hospital for two types of heart attack: NSTEMI and STEMI. Key dates in the spread of the pandemic are also highlighted. Credit: University of Leeds

The graphic can be downloaded by right clicking on this link.

The paper can be found at: https://academic.oup.com/ehjqcco/advance-article/doi/10.1093/ehjqcco/qcaa062/5878960?guestAccessKey=a37491c3-6bc3-41a4-a152-c3ff8195b919

This paper is the first that will investigate the impact of the pandemic on emergency cardiac services. Data will be made available so it can be used by others. That data will be posted at: cardiovascularcovid.leeds.ac.uk

University of Leeds

The University of Leeds is one of the largest higher education institutions in the UK, with more than 38,000 students from more than 150 different countries, and a member of the Russell Group of research-intensive universities. The University plays a significant role in the Turing, Rosalind Franklin and Royce Institutes.??

We are a top ten university for research and impact power in the UK, according to the 2014 Research Excellence Framework, and are in the top 100 of the QS World University Rankings 2020.??

The University was awarded a Gold rating by the Government’s Teaching Excellence Framework in 2017,?recognising?its ‘consistently outstanding’ teaching and learning provision. Twenty-six of our academics have been awarded National Teaching Fellowships – more than any other institution in England, Northern Ireland and Wales – reflecting the excellence of our teaching.??http://www.leeds.ac.uk??

Media Contact
David Lewis
[email protected]

Related Journal Article

http://dx.doi.org/10.1093/ehjqcco/qcaa062

Tags: CardiologyEpidemiologyInfectious/Emerging DiseasesMedicine/HealthPublic Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Synaptic Loss and Connectivity Drops in Depressed PD Mice

Synaptic Loss and Connectivity Drops in Depressed PD Mice

August 13, 2025
blank

Arginine-Infused Dentifrices Demonstrate Significant Reduction in Childhood Dental Caries

August 13, 2025

Author Correction: New Analysis Clarifies Parkinson’s Trial Benefits

August 13, 2025

Micromovement Analysis and Reaction Times Offer New Insights into Predicting Alcohol Relapse After Treatment

August 13, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    140 shares
    Share 56 Tweet 35
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    79 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    58 shares
    Share 23 Tweet 15
  • Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    61 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Synaptic Loss and Connectivity Drops in Depressed PD Mice

Arginine-Infused Dentifrices Demonstrate Significant Reduction in Childhood Dental Caries

Nationwide Study Shows PSMA PET/CT Before Salvage Radiotherapy Enhances Overall Survival in Prostate Cancer Patients

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.